These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34653515)

  • 41. Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children.
    Bastin M; Carr WW; Davis CM; Fleischer DM; Lieberman JA; Mustafa SS; Helleputte T; Bois T; Campbell DE; Green TD; Greenhawt M
    Allergy; 2023 Sep; 78(9):2467-2476. PubMed ID: 36916639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Administration of a probiotic with peanut oral immunotherapy: A randomized trial.
    Tang ML; Ponsonby AL; Orsini F; Tey D; Robinson M; Su EL; Licciardi P; Burks W; Donath S
    J Allergy Clin Immunol; 2015 Mar; 135(3):737-44.e8. PubMed ID: 25592987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral and sublingual immunotherapy for egg allergy.
    Romantsik O; Tosca MA; Zappettini S; Calevo MG
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010638. PubMed ID: 29676439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.
    Sampson HA; Shreffler WG; Yang WH; Sussman GL; Brown-Whitehorn TF; Nadeau KC; Cheema AS; Leonard SA; Pongracic JA; Sauvage-Delebarre C; Assa'ad AH; de Blay F; Bird JA; Tilles SA; Boralevi F; Bourrier T; Hébert J; Green TD; Gerth van Wijk R; Knulst AC; Kanny G; Schneider LC; Kowalski ML; Dupont C
    JAMA; 2017 Nov; 318(18):1798-1809. PubMed ID: 29136445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peanut gastrointestinal delivery oral immunotherapy in adolescents: Results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study).
    Fauquert JL; Michaud E; Pereira B; Bernard L; Gourdon-Dubois N; Rouzaire PO; Rochette E; Merlin E; Evrard B;
    Clin Exp Allergy; 2018 Jul; 48(7):862-874. PubMed ID: 29665158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Risk Reduction of Accidental Exposure-Related Systemic Allergic Reactions Extrapolated Based on Food Challenge Data After 1 Year of Peanut Oral Immunotherapy.
    Yu S; Smith A; Hass S; Wu E; Chai X; Zhou J; Ayyagari R; Liu JS; Robison D; Donelson SM; Tilles S
    Adv Ther; 2021 Aug; 38(8):4321-4332. PubMed ID: 34236672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial.
    Kim EH; Bird JA; Keet CA; Virkud YV; Herlihy L; Ye P; Smeekens JM; Guo R; Yue X; Penumarti A; Qaqish B; Li Q; Kulis MD; Burks AW
    J Allergy Clin Immunol; 2024 Jan; 153(1):173-181.e10. PubMed ID: 37815782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.
    Bird JA; Spergel JM; Jones SM; Rachid R; Assa'ad AH; Wang J; Leonard SA; Laubach SS; Kim EH; Vickery BP; Davis BP; Heimall J; Cianferoni A; MacGinnitie AJ; Crestani E; Burks AW;
    J Allergy Clin Immunol Pract; 2018; 6(2):476-485.e3. PubMed ID: 29092786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An evaluation of factors influencing response to epicutaneous immunotherapy for peanut allergy in the PEPITES trial.
    Fleischer DM; Chinthrajah S; Scurlock AM; Campbell DE; Green TD; Bee KJ; Peillon A; Ocheltree T; Sampson HA
    Allergy Asthma Proc; 2020 Sep; 41(5):326-335. PubMed ID: 32539908
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
    Fleischer DM; Shreffler WG; Campbell DE; Green TD; Anvari S; Assa'ad A; Bégin P; Beyer K; Bird JA; Brown-Whitehorn T; Byrne A; Chan ES; Cheema A; Chinthrajah S; Chong HJ; Davis CM; Ford LS; Gagnon R; Greenhawt M; Hourihane JO; Jones SM; Kim EH; Lange L; Lanser BJ; Leonard S; Mahler V; Maronna A; Nowak-Wegrzyn A; Oriel RC; O'Sullivan M; Petroni D; Pongracic JA; Prescott SL; Schneider LC; Smith P; Staab D; Sussman G; Wood R; Yang WH; Lambert R; Peillon A; Bois T; Sampson HA
    J Allergy Clin Immunol; 2020 Oct; 146(4):863-874. PubMed ID: 32659313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PrEggNut Study: protocol for a randomised controlled trial investigating the effect of a maternal diet rich in eggs and peanuts from <23 weeks' gestation during pregnancy to 4 months' lactation on infant IgE-mediated egg and peanut allergy outcomes.
    Palmer DJ; Sullivan TR; Campbell DE; Nanan R; Gold MS; Hsu PS; Netting MJ; McWilliam V; Koplin JJ; Perrett KP; Quinn P; O'Sullivan M; Prescott SL; Grivell R; Makrides M
    BMJ Open; 2022 Jun; 12(6):e056925. PubMed ID: 35697444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral Immunotherapy for Food Allergy.
    Wood RA
    J Investig Allergol Clin Immunol; 2017; 27(3):151-159. PubMed ID: 28102823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study.
    Vickery BP; Vereda A; Nilsson C; du Toit G; Shreffler WG; Burks AW; Jones SM; Fernández-Rivas M; Blümchen K; O'B Hourihane J; Beyer K; Anagnostou A; Assa'ad AH; Ben-Shoshan M; Bird JA; Carr TF; Carr WW; Casale TB; Chong HJ; Ciaccio CE; Dorsey MJ; Fineman SM; Fritz SB; Greiner AN; Greos LS; Hampel FC; Ibáñez MD; Jeong DK; Johnston DT; Kachru R; Kim EH; Lanser BJ; Leonard SA; Maier MC; Mansfield LE; Muraro A; Ohayon JA; Oude Elberink JNG; Petroni DH; Pongracic JA; Portnoy JM; Rachid R; Rupp NT; Sanders GM; Sharma HP; Sharma V; Sher ER; Sher L; Sindher SB; Siri D; Spergel JM; Sprikkelman AB; Sussman GL; Tsoumani M; Varshney P; Vitalpur G; Wang J; Yang WH; Zubeldia JM; Smith A; Ryan R; Adelman DC
    J Allergy Clin Immunol Pract; 2021 May; 9(5):1879-1889.e13. PubMed ID: 33359589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developing therapies for peanut allergy.
    Bublin M; Breiteneder H
    Int Arch Allergy Immunol; 2014; 165(3):179-94. PubMed ID: 25531161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children.
    Kulis M; Yue X; Guo R; Zhang H; Orgel K; Ye P; Li Q; Liu Y; Kim E; Burks AW; Vickery BP
    Clin Exp Allergy; 2019 Feb; 49(2):180-189. PubMed ID: 30126028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
    Pongracic JA; Gagnon R; Sussman G; Siri D; Oriel RC; Brown-Whitehorn TF; Green TD; Campbell DE; Anvari S; Berger WE; Bird JA; Chan ES; Cheema A; Chinthrajah RS; Chong HJ; Dowling PJ; Fineman SM; Fleischer DM; Gonzalez-Reyes E; Kim EH; Lanser BJ; MacGinnitie A; Mehta H; Petroni D; Rupp N; Schneider LC; Scurlock AM; Sher LD; Shreffler WG; Sindher SB; Stillerman A; Wood R; Yang WH; Bois T; Sampson HA; Bégin P
    J Allergy Clin Immunol Pract; 2022 Jul; 10(7):1864-1873.e10. PubMed ID: 34848381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peanut (
    Casale TB; Irani AM
    Expert Rev Clin Immunol; 2023 Mar; 19(3):253-265. PubMed ID: 36524617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgE binding to linear epitopes of Ara h 2 in peanut allergic preschool children undergoing oral Immunotherapy.
    Dreskin SC; Germinaro M; Reinhold D; Chen X; Vickery BP; Kulis M; Burks AW; Negi SS; Braun W; Chambliss JM; Eglite S; McNulty CMG
    Pediatr Allergy Immunol; 2019 Dec; 30(8):817-823. PubMed ID: 31437325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low-Dose Oral Immunotherapy Using Low-Egg-Allergen Cookies for Severe Egg-Allergic Children Reduces Allergy Severity and Affects Allergen-Specific Antibodies in Serum.
    Maeta A; Matsushima M; Muraki N; Asano M; Takaoka Y; Kameda M; Takahashi K
    Int Arch Allergy Immunol; 2018; 175(1-2):70-76. PubMed ID: 29332094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
    Scurlock AM
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.